Partner With Us
AIRMEITH BIOSCIENCE
Why work with us?
The key to any successful pre-clinical research program is a clear understanding of the questions being asked and a carefully planned strategy to address them. Our mission is to deliver high-quality services that accelerate and de-risk early-stage therapeutic development—helping you generate the robust data needed to move confidently toward later development stages
Long term partnerships
We build enduring collaborations, offering comprehensive, value-added services designed to support your goals throughout pre-clinical development.
Operational Excellence
We are committed to precision, quality, and efficiency across all service lines, ensuring your pre-clinical research moves forward seamlessly.
Anticipating customer needs
Development and integration of new services that align with evolving industry and partner requirements.
Our services
End-to-end management
The key to any successful research project lies in careful planning and an understanding of the limitations of various approaches available i.e. choosing the most suited strategy for your research question. We are happy to provide advice at all stages of your project, whether only considering in vitro investigation as a possible avenue or requiring complete pre-clinical study implementation.
In vitro Services
Transgenic Technologies
Invariably, research programmes are time critical and require precision and quality. Our suite of transgenic technologies including rederivation, cryopreservation, rapid colony expansion ensure the highest welfare standards and scientific excellence in the in vivo model systems we run. We can rederive mice to SOPF status (removal of viruses, bacteria and other endo- or exo- parasites). Cryopreserving mouse models removing unnecessary breeding, risk of disease, erroneous breeding, loss of fecundity or unforeseen disasters including fire and flooding. And in vitro fertilisations allows rapid expansion of mouse colonies to initiate in vivo studies quickly and efficiently.
Novel model generation
Preclinical
Our preclinical platforms enable rigorous, translational evaluation of therapeutic candidates across autoimmune, inflammatory, metabolic, reproductive, and oncology indications. Working primarily with mouse models — with rat capabilities where required — we offer in vivo, ex vivo, and in vitro studies supported by comprehensive immunology, histopathology, behavioural, imaging, and biodistribution endpoints.
Customisation is central to our approach: we can adapt established models or integrate novel genetic modifications to meet specific program needs. Get in touch to learn more about the disease models we offer.
Novel model generation (CRISPR/Cas9)
Genetically-altered animals and cells represent an ever-growing link between understanding the cause of human disease and effective therapeutic development. We offer a full range of capabilities to create knockout, conditional, reporter and humanised genetically altered animals and cells in culture, including gene-modification of existing knockouts. Our highly experienced PhD level staff, ensure fast and efficient delivery of customised projects according to your research needs.